AHL Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$4.78M	Buy	45,604 +1,093	+2%	+$120K	0.07%	501
2017 Q3	$5.02M	Buy	44,511 +17,907	+67%	+$1.95M	0.09%	399
2017 Q2	$2.98M	Buy	26,604 +6,923	+35%	+$782K	0.06%	522
2017 Q1	$2.3M	Sell	19,681 -889	-4%	-$98.4K	0.05%	596
2016 Q4	$2.17M	Buy	20,570 +7,348	+56%	+$770K	0.07%	487
2016 Q3	$1.46M	Buy	13,222 +6,389	+94%	+$846K	0.05%	481
2016 Q2	$995K	Buy	6,833 +1,681	+33%	+$238K	0.05%	446
2016 Q1	$738K	Sell	5,152 -13,641	-73%	-$1.94M	0.05%	468
2015 Q4	$2.9M	Buy	18,793 +15,189	+421%	+$2.22M	0.22%	156
2015 Q3	$515K	Sell	3,604 -32,233	-90%	-$4.51M	0.08%	364
2015 Q2	$5.15M	Sell	35,837 -3,344	-9%	-$477K	0.21%	167
2015 Q1	$5.53M	Buy	39,181 +20,401	+109%	+$3.14M	0.22%	130
2014 Q4	$2.78M	Buy	+18,780	New	+$2.76M	0.14%	276